Delivery Order SPE2DR25D1053-SPE2DR26FT545
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,779.42 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.25 MG transdermal patches (8-count) on September 24, 2025, with completion expected by September 25, 2025. This firm fixed-price, non-competitive delivery order was fulfilled without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,284.92 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.14 mg transdermal patches (8-count package) on September 24, 2025, with completion targeted for September 25, 2025. This non-set-aside contract was competitively awarded on a firm fixed price basis, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued...
- The Defense Logistics Agency (DLA) awarded a $3,430.71 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Combipatch 0.05-0.14 mg transdermal patches (8-count units). This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. Performance is scheduled for completion by September 3,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,136.83 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.25 mg patches (8-count) with an ultimate completion date of August 18, 2025. This non-set-aside contract was competitively awarded and represents a specific product delivery under the company's larger pharmaceutical supply relationship with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,094.93 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.14 MG patches (8-count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for COMBIPATCH 0.05-0.14 MG transdermal patches (8-count packaging) with a ceiling value of $1,679.70. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The ultimate completion date is set for July 14, 2025, and performance will occur at the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $1,295.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COMBIPATCH TDBW 8S on October 29, 2025, with an ultimate completion date of November 26, 2025. This non-set-aside contract represents a pediatric or specialized pharmaceutical delivery under the company's existing relationship with DLA's medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for COMBIPATCH 0.05-0.14 mg patches in a quantity of 8 units. This is a firm fixed price delivery order with a ceiling value of $1,743.72 and an ultimate completion date of August 14, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,791.52 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Combipatch 0.05-0.14 mg patches (8-count units). This is a firm fixed price, non-set-aside contract with a completion date of July 31, 2025, and performance occurring at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier for federal...
- The Defense Logistics Agency awarded a $2,254.84 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of COMBIPATCH 0.05-0.14 MG transdermal patches (8-count packaging), with completion expected by September 18, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT545Delivery Order
The Defense Logistics Agency awarded a $2,151.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.25 MG transdermal patches (8-count packaging) on November 3, 2025, with an ultimate completion date of November 4, 2025. The contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated substantial capability in fulfilling Defense Logistics Agency requirements across multiple therapeutic domains through competitively awarded contracts. The company's extensive federal contract portfolio includes diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies, with delivery orders ranging from minimal to substantial values. The DLA Troop Support is currently planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, reflecting the strategic importance of vendors like AmerisourceBergen in supporting Department of Defense healthcare operations and the Defense Health Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 11/3/25 |